JAZMIN LOWE: Open Payments
NPI 1265935589 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,134 in 157 payments from 36 companies in 2025. Trend: 2023 $1,360 · 2024 $4,242 · 2025 $4,134
Food & beverage: $2,787Long term medical supply or device loan: $1,147Education: $200
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 33 | $1,564 |
| PFIZER INC. | 12 | $256 |
| Janssen Biotech, Inc. | 8 | $223 |
| Daiichi Sankyo Inc. | 9 | $211 |
| Celgene Corporation | 18 | $211 |
| E.R. Squibb & Sons, L.L.C. | 12 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Pharmacosmos Therapeutics Inc. | 6 | $113 |
| SEAGEN INC. | 1 | $100 |
| Incyte Corporation | 4 | $95 |
Products named: KISQALI, Enhertu, REBLOZYL, ERLEADA, Fabhalta, OPDIVO, MONOFERRIC, CALQUENCE.
Industry payments across TN — which companies pay providers there.
